Evidence map›Paper›PMID 30702347›Full record

SynthesisCirculation. Genomic and precision medicine2019

Thyroid Function and Dysfunction in Relation to 16 Cardiovascular Diseases.

Susanna C Larsson, Elias Allara, Amy M Mason, Karl Michaëlsson, Stephen Burgess

Open access · greenAbstract readMeta-Analysis
In one paragraph

Synthesis in Circulation. Genomic and precision medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 6 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 6 syntheses or guidelines pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Review
  8. Article
  9. Genetics of Thyroid Function: Relevance for Biology and Disease Management.The Journal of clinical endocrinology and metabolism · 2025
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Susanna C LarssonDepartment of Surgical Sciences, Uppsala University, Sweden (S.C.L., K.M.).
Elias AllaraDepartment of Public Health and Primary Care (E.A., A.M.M., S.B.).
Amy M MasonDepartment of Public Health and Primary Care (E.A., A.M.M., S.B.).
Karl MichaëlssonDepartment of Surgical Sciences, Uppsala University, Sweden (S.C.L., K.M.).
Stephen BurgessDepartment of Public Health and Primary Care (E.A., A.M.M., S.B.).
Primary Health Care · QA

Funding

British Heart Foundation RG/13/13/30194British Heart Foundation RG/18/13/33946Medical Research Council MC_UU_00002/7Wellcome Trust 204623/Z/16/Z
6 · The paper itself

Abstract

backgroundSubclinical thyroid dysfunction, defined as thyroid-stimulating hormone levels outside the reference range with normal free thyroxine levels in asymptomatic patients, is associated with alterations in cardiac hemodynamics. We used Mendelian randomization to assess the role of thyroid dysfunction for cardiovascular disease (CVD).

methodsSingle-nucleotide polymorphisms associated with thyroid function were identified from a genome-wide association meta-analysis in up to 72 167 individuals. Data for genetic associations with CVD were obtained from meta-analyses of genome-wide association studies of atrial fibrillation (n=537 409 individuals), coronary artery disease (n=184 305 individuals), and ischemic stroke (n=438 847) as well as from the UK Biobank (n=367 703 individuals).

resultsGenetically predicted thyroid-stimulating hormone levels and hyperthyroidism were statistically significantly associated with atrial fibrillation but no other CVDs at the Bonferroni-corrected level of significance ( P<7.8×10

conclusionsThis Mendelian randomization study supports evidence for a causal association of decreased thyroid-stimulating hormone levels in the direction of a mild form of hyperthyroidism with an increased risk of atrial fibrillation but no other CVDs.

Indexed as

Atrial FibrillationCardiovascular DiseasesDatabases, FactualGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansHyperthyroidismOdds RatioPolymorphism, Single NucleotideThyroid GlandThyrotropinThyroxineThyrotropinThyroxineatrial fibrillationcardiovascular diseasehormoneshyperthyroidismthyrotropin

Identifiers

PMID30702347
PMCPMC6443057
OpenAlexW2927054219

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.